Treatment of Cutibacterium acnes Infections

First-Line Therapies

The American Academy of Dermatology recommends topical benzoyl peroxide combined with topical retinoids and/or topical antibiotics as first-line therapy for acne vulgaris, with oral doxycycline as the preferred systemic antibiotic for moderate-to-severe inflammatory acne 1, 2
Topical retinoids are strongly recommended as they are comedolytic, resolve microcomedone lesions, and are anti-inflammatory, according to the American Academy of Dermatology 1, 3

The American Academy of Dermatology recommends doxycycline 100mg daily as the first-line oral antibiotic for moderate-to-severe inflammatory acne that is widespread or resistant to topical treatments 2
Minocycline 50-100mg daily is recommended as a second-line option if doxycycline is not tolerated, although it carries a higher risk of serious adverse effects 2
The treatment duration for oral antibiotics should be limited to 3-4 months maximum to minimize bacterial resistance, as recommended by the American Academy of Dermatology 2

Oral isotretinoin is strongly recommended for severe acne, acne causing psychosocial burden or scarring, or acne failing standard oral/topical therapy, according to the American Academy of Dermatology 1

Diagnosis of implant-associated C. acnes infections requires deep tissue biopsy with prolonged anaerobic culture, and at least two separate deep tissue specimens with identical pathogens are needed to confirm infection 4
Beta-lactams, clindamycin, doxycycline/tetracyclines, or rifampicin are recommended for antibiotic treatment, with clindamycin preferred for biofilm activity 4
Treatment duration for implant-associated C. acnes infections is 3 months total, and rifampicin must always be combined with a second agent to prevent resistance emergence 4

Tetracyclines are contraindicated in children under 8 years or pregnant patients due to tooth discoloration risk and pregnancy category D, and macrolides or topical therapy should be considered instead 2, 3
Combined oral contraceptives or spironolactone may be considered as alternatives or adjuncts for females with hormonal acne patterns, according to the American Academy of Dermatology 1, 2